BVAXF (BVAXF) Stock Price & Analysis
BVAXF (BVAXF) fell 1.41% to USD 0.17 as of June 10, 2026 at 07:06 UTC, according to Nexqual real-time market data.
BVAXF last closed at USD 0.17; the session ranged USD 0.17–0.17 on volume of 1,100 shares. Market capitalization is $6.81M, with a 52-week range of USD 0.02–0.3 (PNK). Source: Nexqual, June 10, 2026 at 07:06 UTC.
Key Statistics (as of June 10, 2026 at 07:06 UTC)
| Price | USD 0.17 |
|---|---|
| Change | ▼ 1.41% (down) |
| Previous Close | USD 0.17 |
| Open | USD 0.17 |
| Day Range | USD 0.17 – 0.17 |
| 52-Week Range | USD 0.02 – 0.3 |
| Volume | 1,100 shares |
| Market Cap | $6.81M |
| Exchange | PNK |
Technical Analysis (BVAXF)
Nexqual's technical model rates BVAXF "BUY" based on 5 bullish and 1 bearish signals across 124 daily candles, as of June 10, 2026 at 07:06 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 65.03 (neutral) |
| vs SMA50 | Above (USD 0.09) |
| MACD | 0.02 (positive) |
Analyst Ratings (BVAXF)
Wall Street analysts rate BVAXF "None", per Nexqual as of June 10, 2026 at 07:06 UTC.
| Consensus Rating | None |
|---|
Earnings (BVAXF)
Source: Nexqual, June 10, 2026 at 07:06 UTC.
Financials & Fundamentals (BVAXF)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| Current Ratio | 0.28 |
| Total Cash | $4,080 |
| Total Debt | $133,720 |
| Free Cash Flow | $-1.03M |
Source: Nexqual, June 10, 2026 at 07:06 UTC.
Financial Health Score (BVAXF)
Nexqual rates BVAXF's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 07:06 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Gross margin 0%, operating 0% |
| Balance Sheet | Mixed — $4K cash, no debt |
| Cash Flow | Weak — Operating cash flow -$3M |
| Efficiency | Mixed — No data |
Ownership (BVAXF)
| Insider Ownership | +8.23% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 40.65M |
| Float | 26.14M |
Source: Nexqual, June 10, 2026 at 07:06 UTC.
Leadership (BVAXF)
BVAXF is led by James Christopher Passin (age 53), Co-Founder, CEO, & Director, per Nexqual as of June 10, 2026 at 07:06 UTC.
| Co-Founder, CEO, & Director | James Christopher Passin (age 53) |
|---|---|
| Co-Founder, President & COO | Kenneth E. Kovan (age 63) |
| Chief Financial Officer | Christopher P. Cherry |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BZWR | Business Warrior Corporation | USD 0 | ▲ 0% |
| CCWF | Church & Crawford, Inc. | USD 0 | ▲ 0% |
| CCAJ | Coastal Capital Acquisition Cor | USD 0 | ▼ 15% |
| BIOAF | BIOASIS TECHNOLOGIES INC | USD 0 | ▲ 0% |
| STAL | Star Alliance International Cor | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 07:06 UTC. This page is informational and not investment advice.